Grown Rogue International (GRUSF) Amortizatization of Intangibles (2010 - 2026)

Grown Rogue International's (GRUSF) quarterly Amortizatization of Intangibles came in at $42210.0 in Q1 2026, down 80.83% year-on-year from $220133.0 in Q1 2025, and up 100.0% quarter-over-quarter from -$812.2 billion in Q4 2025.

Grown Rogue International (GRUSF) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends

Grown Rogue International's Amortizatization of Intangibles history runs 11 years deep, the most recent figure standing at $42210.0 for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 80.83% year-over-year to $42210.0 in Q1 2026; TTM through Mar 2026 was -$177923.0, a 110.62% decrease from a year earlier, with the FY2024 full-year figure at $1.8 million, up 748.27% from the prior year.
  • Amortizatization of Intangibles advanced to $42210.0 in Q1 2026 per GRUSF's latest filing, from -$812.2 billion in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1531.6 billion in Q3 2024 and bottomed at -$1531.5 billion in Q4 2024.
  • The 5-year median for Amortizatization of Intangibles is $294195.5 (2025), against an average of $263617.2.
  • Across the five-year window, Amortizatization of Intangibles surged 46.97% in 2025 and tumbled 80.83% in 2026, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $151685.0 in 2022, then soared by 468.69% to $862624.0 in 2023, then tumbled by 177545492.15% to -$1531.5 billion in 2024, then jumped by 46.97% to -$812.2 billion in 2025, then soared by 100.0% to $42210.0 in 2026.
  • Per Business Quant, the three latest GRUSF Amortizatization of Intangibles figures stand at $42210.0 (Q1 2026), -$812.2 billion (Q4 2025), and $812.2 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.30 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Grown Rogue International 99.97 Mn 86.26 Mn 3.96 Mn 42,210.00

Historic Data

Download Data
DateValue
Mar 31, 2026 42,210.00
Mar 31, 2026 42,210.00
Dec 31, 2025 -812.21 Bn
Dec 31, 2025 -812.21 Bn
Sep 30, 2025 812.21 Bn
Sep 30, 2025 812.21 Bn
Jun 30, 2025 368,258.00
Jun 30, 2025 368,258.00
Mar 31, 2025 220,133.00
Mar 31, 2025 220,133.00
Dec 31, 2024 -1,531.55 Bn
Dec 31, 2024 -1,531.55 Bn
Sep 30, 2024 1,531.55 Bn
Sep 30, 2024 1,531.55 Bn
Jun 30, 2024 378,404.00
Jun 30, 2024 378,404.00
Mar 31, 2024 381,663.00
Mar 31, 2024 381,663.00
Oct 31, 2023 862,624.00
Oct 31, 2023 862,624.00